Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review

Kevin S Tang, Shoujit Banerjee, George Tang, Pranav M Patel, Antonio H Frangieh · 2023

Read Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review by Kevin S Tang, Shoujit Banerjee, George Tang, Pranav M Patel, Antonio H Frangieh (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10782423.txt.

Description

Kevin Tang and four co-authors review how long patients should take two blood-thinning drugs after a heart stent is placed. Their 2023 review notes that stents have improved fast, yet the right length of dual therapy stayed debated. The pair of drugs guards against clots in the stent, but it also raises the risk of bleeding.

Older guidance favored twelve months of dual therapy, and longer for some patients. Newer trials and safer drug-coated stents have shifted the field toward shorter courses. Cutting months of therapy lowers major bleeding while modern stents keep clot risk in check. The authors walk through current guidelines, the fresh proof behind them, and the gaps that remain. Heart teams can use the review to tailor duration to each patient's clot and bleed risks.

Catalog record

CREATORKevin S Tang, Shoujit Banerjee, George Tang, Pranav M Patel, Antonio H Frangieh
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10782423

Browse the full library · About the Tower of Babel